Home / Drugs / lerodalcibep-liga

lerodalcibep-liga

FDA Drug Profile — LEROCHOL

Drug Details

Generic Name
lerodalcibep-liga
Brand Names
LEROCHOL
Application Number
BLA761427
Sponsor
LIB Therapeutics, Inc.
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
LERODALCIBEP

Indications and Usage

1 INDICATIONS AND USAGE LEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). LEROCHOL is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor indicated as an adjunct to diet and exercise: to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). ( 1 )